Status:
RECRUITING
Comparing Two Ways to Manage Head and Neck Lymphedema
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
Head and Neck Cancer
Lymphedema
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomized clinical trial aims to compare clinic-based CDT and home-based (a hybrid model) CDT on changes in the severity of lymphedema, symptom burden, functional status, and healthcare utilizat...
Detailed Description
Primary aim: To compare the effects of clinic-based and home-based (a hybrid model) CDT on changes in the severity of lymphedema. Secondary aim: To compare the effects of clinic-based and home-based ...
Eligibility Criteria
Inclusion
- \>18 years of age
- \<=24 months post-HNC treatment
- Diagnosis of head and neck lymphedema and referral by their oncology providers
- Able to perform self-manual lymphatic drainage
- Having an electronic device (a computer, tablet, iPad, laptop, or smartphone) and internet access at home
Exclusion
- Active infection in soft tissues in the head and neck region
- History of moderate or severe carotid artery occlusion
- Significantly severe lymphedema (e.g., severe periorbital swelling)
- Conditions impacting the safe delivery of lymphedema therapy
Key Trial Info
Start Date :
March 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05182229
Start Date
March 11 2022
End Date
November 30 2026
Last Update
April 30 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Jefferson Cherry Hospital Jefferson Health
Cherry Hill, New Jersey, United States, 08002
2
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
3
Jefferson Health
Philadelphia, Pennsylvania, United States, 19107
4
Jefferson Torresdale Hospital Jefferson Health
Philadelphia, Pennsylvania, United States, 19114